Richard Dennis joined the Charity in April 2021. Since 2017 to date he holds the position of Chief Commercial Officer and Executive Director at Proteome Sciences plc, an AIM listed proteomics based company.
He has a commercial background spanning over 30 years in the global life sciences research sector. Throughout his career he has held positions based in both UK and US managing international sales teams. In 1991, he joined Oxford Glycosciences, a VC backed company based in Abingdon UK and was responsible for commercializing their novel glycoprotein detection systems globally. In 1996, he moved to NASDAQ listed Molecular Devices as the European and Middle East as Director of Sales, selling their range of both microplate readers and automated protein based drug discovery platforms largely to the pharma sector.
He was the first EU based employee of Meso Scale Discovery (MSD) and set up and managed their direct selling organization in Europe and Asia/Pacific from 2001; MSD introduced a novel ELISA based technology into the sector. Before joining Proteome Sciences he had a similar role for four years at Quanterix Corporation, a Boston based company commercializing high sensitivity protein detection platforms